article thumbnail

Bridging the healthcare digital divide: a gradual approach to adopting ePI

European Pharmaceutical Review

They are vital to ensuring the safe and effective use of medicines, making them an integral part of healthcare in Europe. 3 Moreover, digital platforms can be tailored to the needs of patients and healthcare professionals, offering accessible, trustworthy and up-to-date information on medicines precisely when required.

article thumbnail

Now alcohol is a direct cause of cancer

World of DTC Marketing

The question is will the healthcare community do anything about these findings? Endpoints recently wrote, “between 2009 and 2020, prices increased — with one exception — within and across all 12 cancer drug classes studied in the U.S., ” So now, in addition to obesity, alcohol is killing us. And what are we doing about it?

Insurance 249
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The current pricing of cancer treatments is unsustainable

World of DTC Marketing

From 2009 to 2019, the median monthly treatment costs for new drugs at launch reached $11,755 in the U.S… From 2009-10 to 2018-19, the lowest average monthly costs for new cancer drugs approved by the U.S. SUMMARY: The U.S. needs to take substantial steps to address the high costs of cancer drugs.

article thumbnail

The current pharma business model is unsustainable

World of DTC Marketing

While that sounds encouraging, most cancer drugs launched between 2009 and 2014 cost more than USD 100,000 annually. For DTC, the model will become one of collaboration with patients as they help them navigate the complex system of American healthcare. ASH Clinical News takes it a step further.

Pharma 210
article thumbnail

Unleashing the power of healthcare analytics data to improve patient loyalty and referrals

Clarify Health

Most healthcare providers’ priorities include retaining patients and improving referral patterns to increase revenue. To achieve this, they evaluated different healthcare analytics and technology solutions available on the market.

article thumbnail

Biogen’s $900 million settlement signals scrutiny on speaker fees

Pharmaceutical Technology

In 2009, former Biogen employee Michael Bawduniak filed a lawsuit claiming that Biogen had violated the False Claims Act and the Anti-Kickback Statute by providing millions of dollars to healthcare providers (HCPs) as an incentive to prescribe three of its multiple sclerosis (MS) drugs.

article thumbnail

Ritesh Patel

Pharma Marketing Network

Along the way, he has worked for the likes of Havas, Cushman & Wakefield and began a deep dive into the healthcare arena in 2009 when he joined Inventiv Health as Head of Digital & innovation. The Lab has been responsible for showcasing the art of the possible.